| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.0M | -7.3% |
| Cost of Revenue | $4.7M | -13.1% |
| Gross Profit | $1.3M | +21.9% |
| R&D Expense | $363K | -54.4% |
| SG&A Expense | $5.0M | +11.8% |
| Operating Income | -$4.1M | -19.3% |
| Pre-tax Income | -$3.9M | -22.7% |
| Income Tax | $32K | +76.9% |
| Net Income | -$4.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -44.7% |
| Accounts Receivable | $1.3M | +354.6% |
| Inventory | $148K | -54.4% |
| Current Assets | $5.0M | -15.2% |
| Total Assets | $5.2M | -28.7% |
| Current Liabilities | $2.3M | +57.5% |
| Long-term Debt | $376K | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | -69.7% |
| Investing Cash Flow | -$3K | +99.7% |
| Financing Cash Flow | $2.3M | +144.6% |
| -23.0% |
| EPS (Basic) | -$1.81 | -805.0% |
| EPS (Diluted) | -$1.81 | -805.0% |
| Stockholders' Equity |
| $2.5M |
| -56.8% |